TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial.

S M Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.